SUMO fusion for genome-wide protein analysis

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$1,221,710.00
Award Year:
2005
Program:
SBIR
Phase:
Phase II
Contract:
2R44GM067271-02
Agency Tracking Number:
GM067271
Solicitation Year:
2005
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2005-2
Small Business Information
LIFESENSORS, INC.
Lifesensors, Inc., 271 Great Valley Pky, Malvern, PA, 19355
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
TAUSEEF BUTT
(610) 644-8845
butt@lifesensors.com
Business Contact:
VARSHA LUTHRA
(610) 644-8845
BUTT@LIFESENSORS.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): A vast number of novel proteins discovered from genome sequencing projects are creating enormous opportunities for scientists in academia and industry. Large-scale consortia and initiatives are underway to understand the structures of newly discovered proteins. Unfortunately, protein expression and purification are a major bottleneck. Bacteria are usually the first system of choice for recombinant protein expression. In phase I, LifeSensors proposed the development of a novel SUMO-fusion system to enhance expression and purification of wide variety of proteins in E. coli. The SUMO protein acts as a chaperone to promote enhanced expression as well as solubility of inclusion body proteins. SUMO fusion is also used as a handle for rapid purification of partner proteins. In phase I, a comparative study was conducted to determine the effectiveness of the SUMO expression system with other leading fusion technologies. Data showed that the SUMO system was superior to the five leading fusion systems in enhancing expression and solubility of proteins in E. coli. The phase I proposal was centered on the yeast SUMO tag and SUMO protease. In phase II, LifeSensors proposes to build on its success to broaden the scope of SUMO system by identifying new enzymes and rigorously testing the system with difficuIt-to-express proteins. Since the insect cell system has developed as a model for eukaryotic expression, it is proposed in Phase II to develop and market a SUMO system for insect cells. Development of a system that enhances expression of proteins and offers rapid purification tools at the genomic level will greatly aid post-genomic expression and protein array technologies.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government